Bupa UK has announced a four-year agreement with Spire Healthcare which will build on the provider’s recent cancer specialist centres.
The partnership, which will run through to March 2026, will also see the introduction of new pathways for musculoskeletal disorders such as tendinitis, carpal tunnel syndrome, osteoarthritis, rheumatoid arthritis (RA), fibromyalgia and bone fractures. The contract between Bupa and Spire Healthcare follows on from the insurer's recent partnership with HCA Healthcare to launch specialist centres for patients with bowel cancer. The centres will aim to provide patients access to diagnostic tests and, if required, onward care at a much faster pace by offering all initial cancer testing und...
To continue reading this article...
Join COVER for free
- Unlimited access to real-time news, key trend analysis and industry insights.
- Stay on top of the latest developments around health and wellbeing, diversity and inclusion and the cost of living crisis.
- Receive breaking news stories straight to your inbox in the daily newsletter.
- Members only access to monthly programme 'The COVER Review'
- Be the first to hear about our CPD accredited events and awards programmes.